is semaglutide good for diabetes Semaglutide. Tirzepatide. The names dominate headlines: “Game-changing weight loss injections.” “A revolution in care.” But beyond the buzz, here's what the evidence says: Glycemic control: Landmark trials (SURPASS, SUSTAIN) show significant Type 2 diabetes: New Ozempic

A healthcare professional should address swelling that doesnt subside within a few weeks or worsens over time

M., Leone, A., Laudani, R., Martin, R., Deinit, G., and Cataldi, V

Companies need blog posts, website copy, product descriptions, and email campaigns

Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed by the MHRA for weight management, administered as a once-weekly injection

It is known as a dual agonist because it mimics two different hormones in the body: Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP)

Note also that 5067% of users discontinue within 1 year and 85% within 2 years (joint advisory), which is when muscle preserved during treatment pays off